Nu-Med Plus Inc (NUMD)
OTHER OTC:NUMD
Total Valuation
Nu-Med Plus has a market cap or net worth of $852.19K. The enterprise value is $970.41K.
Market Cap$852.19K
Enterprise Value$970.41K
Share Statistics
Nu-Med Plus has 83,548,470 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding83,548,470
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Nu-Med Plus’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 30.83%.
Return on Equity (ROE)0.21
Return on Assets (ROA)-7.10
Return on Invested Capital (ROIC)30.83%
Return on Capital Employed (ROCE)0.18
Revenue Per Employee0.00
Profits Per Employee-28.09K
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Nu-Med Plus is ―. Nu-Med Plus’s PEG ratio is 2.06.
PE Ratio―
PS Ratio0.00
PB Ratio-5.32
Price to Fair Value-5.32
Price to FCF-30.09
Price to Operating Cash Flow-15.68
PEG Ratio2.06
Income Statement
In the last 12 months, Nu-Med Plus had revenue of 0.00 and earned -56.18K in profits. Earnings per share was >-0.01.
Revenue0.00
Gross Profit0.00
Operating Income-48.95K
Pretax Income-56.18K
Net Income-56.18K
EBITDA-48.95K
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -54.36K and capital expenditures 0.00, giving a free cash flow of -54.36K billion.
Operating Cash Flow-54.36K
Free Cash Flow-54.36K
Free Cash Flow per Share>-0.01
Dividends & Yields
Nu-Med Plus pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.71
52-Week Price Change-80.00%
50-Day Moving Average0.01
200-Day Moving Average0.02
Relative Strength Index (RSI)28.75
Average Volume (3m)7.63K
Important Dates
Nu-Med Plus upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Nu-Med Plus as a current ratio of 0.03, with Debt / Equity ratio of -42.66%
Current Ratio0.03
Quick Ratio0.03
Debt to Market Cap0.08
Net Debt to EBITDA-2.28
Interest Coverage Ratio6.77
Taxes
In the past 12 months, Nu-Med Plus has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Nu-Med Plus EV to EBITDA ratio is -31.78, with an EV/FCF ratio of -32.42.
EV to Sales0.00
EV to EBITDA-31.78
EV to Free Cash Flow-32.42
EV to Operating Cash Flow-32.42
Balance Sheet
Nu-Med Plus has $4.28K in cash and marketable securities with $122.50K in debt, giving a net cash position of -$118.22K billion.
Cash & Marketable Securities$4.28K
Total Debt$122.50K
Net Cash-$118.22K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Nu-Med Plus is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast25.00%